Electrolytes Flashcards
Potassium
Potassium is a predominantly intracellular ion
Normal range is between 3.5 and 5.0mmol/l
It is absorbed from the small intestine
It’s entry into cells is controlled by the Na/K ATPase pump
It is 90% renally excreted
It regulates acid base balance and maintains the RMP
Hypokalaemia - Causes
Hyperkalaemia = K <3.5mmol/l and causes include:
- Redistribution: alkalosis, hypoMg, refeeding syndrome, drugs (beta agonists, catecholamines, insulin)
- Abnormal intake: inadequate intake or supplementation
- Abnormal losses: Urinary - steroids, DKA, hyperaldosteronism, diuretics, diuretic phase of AKI & GI - vomiting and diarrhoea
Hypokalaemia - Clinical Features
CNS: Weakness, cramps, paralysis, hyporeflexia
CVS: Hypertension (Na retention), dysrhythmias, tall wide P waves, T wave flatting and inversion, ST depression, U waves, prolonged QT, progression to ventricular arrhythmias
GI: Nausea, vomiting, constipation, ileus
Hypokalaemia - Management
Principles include:
- An A-E approach
- Replace potassium (and magnesium if necessary)
- Monitor ECG and electrolytes
- Prevent recurrence
Hyperkalaemia - Causes
Hyperkalaemia = K >5.5mmol/l and causes include:
- Redistribution: Acidosis, Rhabdomyolysis, tumour lysis, insulin deficiency (including DKA), haemolysis, drugs (sux, digoxin, beta-blockers)
- Abnormal intake: High potassium foods, blood transfusion
- Abnormal losses: Urinary - renal failure, adrenal insufficiency, drugs (potassium sparing diuretics, ACEi, ARBs)
Hyperkalaemia - Clinical Features
CVS: Hypotension, arrhythmias, wide flat P wave, prolonged PR, wide QRS, AV and conduction blocks, bradyarrhythmia, PEA or VFib
GI: Nausea, vomiting
Hyperkalaemia - Management
General principles include:
- An A-E approach
- Stop administration/ treat underlying cause
- Move potassium into cells: Salbutamol, Insulin-Glucose
- Protect the myocardium (calcium)
- Remove the potassium (diuretics/ RRT)
- Prevent recurrence
Magnesium
Magnesium is a predominantly intracellular ion
Normal range is 0.7-1.0mmol/l
Absorbed in the small intestine
50-60% stored in bone
Only a small amount renally excreted
Involved in enzyme systems such as ATPase, antagonises calcium
Hypomagnesaemia - Causes
Hypomagnesaemia is defined as a Mg <0.7mmol/l
Redistribution: Refeeding syndrome, insulin, post- parathyroidectomy
Abnormal intake: TPN, malabsorption, alcoholism (malnutrition)
Abnormal losses: Urinary: RTA, diuretics, polyuria, hyperaldosteronism, hypercalcaemia & GI: Vomiting, acute pancreatitis, diarrhoea
Hypomagnesaemia - Clinical features
Often co-exists with hypoCa, hypoK
CNS: Weakness, ataxia, tremor, coma
CVS: Hypertension, angina, arrhythmia, prolonged QT, signs of hypoK, VT (incl. Torsades)
GI: nausea, vomiting, abdominal pain
Hypomagnesaemia - Management
General principles include:
- Replace Mg
- Monitor ECG & electrolytes
- Prevent recurrence
Hypermagnesaemia - Causes
Hypermagnesaemia is defined as a Mg >1.0mmol/l
It is invariably iatrogenic
- Abnormal intake: excess supplementation, think obstetrics
- Abnormal losses: Urinary - renal failure
Hypermagnesaemia - Clinical Features
Magnesium antagonises Ca entry into cells
CNS: Weakness, coma
CVS: Conduction abnormalities
GI: Nausea/ vomiting
Hypermagnesaemia - Management
General principles include:
- An A-E approach
- Stop administration
- Give calcium (antagonises Mg)
- Monitor ECG and electrolytes
- Prevent recurrence
Phosphate
A predominantly intracellular ion
Normal phosphate is 0.85-1.4mmol/l
Absorbed in the small intestine
85% found in bone
PTH causes phosphate resorption from bone and reduces reabsorption in PCT
Calcitonin, Mg, Bicarbonate increase excretion
Needed for ATP
Hypophosphataemia - Causes
Defined as a PO4 <0.85mmol/l
Redistribution: Refeeding syndrome, respiratory alkalosis, insulin in DKA, glucagon, cortisol, adrenaline (causes intracellular shift)
Abnormal intake: Malnutrition, phosphate binders, malabsorption, TPN
Abnormal losses: Urinary: RTA, hyperaldosteronism; GI: diarrhoea; Other: Sweat, burns, bleeding
Hypophosphataemia - Clinical Features
Often an incidental finding and co-exists with hypoK, hypoMg
Neuro: Proximal myopathy, weakness, smooth muscle dysfunction
CVS: Acute cardiomyopathy
Hypophosphataemia - Management
- Replace phosphate
- Monitor (watch for hypoCa also)
- Prevent recurrence
Hyperphosphataemia - Causes
Defined as a PO4 >1.4mmol/l
Redistribtion: Rhabdomyolysis, tumour lysis, malignant hyperpyrexia, haemolysis, acidosis
Abnormal intake: Increased intake, enemas, VitD intoxication
Abnormal losses: Urinary: Renal failure, hypo parathyroid sim, hypoMg
Hyperphosphataemia - Clinical Features
Binds with calcium to cause HypoCa
Neuro: Tetany
Renal: Calculus formation
Hyperphosphataemia - Management
- Stop administration
- Bind phosphate (aluminium hydroxide)
- Remove phosphate (RRT and volume repletion)
- Monitor
- Prevent recurrence
Calcium
A predominantly extracellular ion
Normal concentration in plasma is 2.2-2.6mmol/l
Exists in plasma as free ions, bound to proteins (40-50%) and diffusible complexes
PTH ensures control of ionised calcium by INCREASING release from bone, reabsorption from DCT, converting VitD to increase GI absorption
Calcitonin released from thyroid opposes PTH
Hyopcalcaemia - Causes
Hypocalcaemia is defined as a serum Ca <2.2mmol/l
Redistribution: Alkalosis, citrate toxicity, blood administration, hyperphosphataemia, pancreatitis, tumour lysis, rhabdomyolysis, hypoparathyroidism, drugs (PPIs, SSRIs)
Abnormal intake: Low dietary Ca, low VitD, phenytoin (increases VitD metabolism)
Abnormal losses: Urinary: ethylene glycol, cisplatin, loop diuretics; Other: bleeding, plasmapheresis, citrate RRT
Hyopcalcaemia - Clinical Features
Neuro: Mental state changes, tetany, facial muscle contracture, carpopedal spasm
CVS: Prolonged QTc, AV block, Torsades